This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ekekezie, I. I.
Right arrow Articles by Truog, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ekekezie, I. I.
Right arrow Articles by Truog, W. E.
PEDIATRICS Vol. 113 No. 6 June 2004, pp. 1709-1714

Low Levels of Tissue Inhibitors of Metalloproteinases With a High Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Are Present in Tracheal Aspirate Fluids of Infants Who Develop Chronic Lung Disease

Ikechukwu I. Ekekezie, MD*, Donald W. Thibeault, MD*, Stephen D. Simon, PhD{ddagger}, Michael Norberg*, Jeffrey D. Merrill, MD§, Roberta A. Ballard, MD§, Philip L. Ballard, MD, PhD§ and William E. Truog, MD*

* Children’s Mercy Hospitals and Clinics, University of Missouri-Kansas City, School of Medicine, Department of Pediatrics, Section of Neonatal-Perinatal Medicine, Kansas City, Missouri
{ddagger} Office of Medical Research, Section of Biostatistics, Kansas City, Missouri
§ Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Department of Pediatrics, Section of Neonatology, Philadelphia, Pennsylvania

Objective. The pathogenesis of chronic lung disease (CLD) involves inflammation with proteolytic damage to lung extracellular matrix. Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that, acting in concert with their tissue inhibitors, tightly orchestrate extracellular matrix morphogenesis and repair after injury. Imbalances in their levels relative to that of their inhibitors have been implicated in diseases characterized by matrix disruption and remodeling. We investigated the possibility that imbalances in MMP-9 and MMP-2 relative to their tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2, respectively, in tracheal aspirates of preterm infants may be involved in the development of CLD.

Methods. Serial tracheal aspirates collected from birth until extubation in 49 ventilated preterm infants (24-32 weeks’ gestations) were analyzed for MMP-2, MMP-9, TIMP-1, and TIMP-2. Data normalized by TA values of free secretory component of immunoglobulin A were compared for CLD (n = 22) versus no CLD (n = 27). Also, known clinical predictors of CLD (gestational age, birth weight, and sex) were assessed for both groups. Association of predictors with the outcome CLD was assessed by logistic regression.

Results. Mean gestational age was lower in CLD infants, but birth weight and gender were comparable for both groups. CLD infants had significantly lower TIMP-1 level with higher MMP-9/TIMP-1 ratio during the first 2 weeks of life and low TIMP-2 and MMP-2 levels during the first 3 days of life compared with no-CLD infants. Logistic regression analysis indicated that the findings are predictive of CLD.

Conclusions. We conclude that low tracheal aspirate levels of TIMPs, with a high MMP-9/TIMP-1 ratio early in life, are associated with subsequent development of CLD.


Key Words: MMPs • TIMPs • chronic lung disease

Abbreviations: CLD, chronic lung disease • MMP, matrix metalloproteinase • TIMP, tissue inhibitor of metalloproteinase • RDS, respiratory distress syndrome • TAF, tracheal aspirate fluid • EIA, enzyme immunoassay


Received for publication Mar 10, 2003; Accepted Sep 15, 2003.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Chetty, G.-J. Cao, M. Severgnini, A. Simon, R. Warburton, and H. C. Nielsen
Role of matrix metalloprotease-9 in hyperoxic injury in developing lung
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L584 - L592.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Farhath, Z. He, T. Nakhla, J. Saslow, S. Soundar, J. Camacho, G. Stahl, S. Shaffer, D. I. Mehta, and Z. H. Aghai
Pepsin, a Marker of Gastric Contents, Is Increased in Tracheal Aspirates From Preterm Infants Who Develop Bronchopulmonary Dysplasia
Pediatrics, February 1, 2008; 121(2): e253 - e259.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. V. Cockle, N. Gopichandran, J. J. Walker, M. I. Levene, and N. M. Orsi
Matrix Metalloproteinases and Their Tissue Inhibitors in Preterm Perinatal Complications
Reproductive Sciences, October 1, 2007; 14(7): 629 - 645.
[Abstract] [PDF]


Home page
PediatricsHome page
W. E. Truog, P. L. Ballard, M. Norberg, S. Golombek, R. C. Savani, J. D. Merrill, L. A. Parton, A. Cnaan, X. Luan, R. A. Ballard, et al.
Inflammatory Markers and Mediators in Tracheal Fluid of Premature Infants Treated With Inhaled Nitric Oxide
Pediatrics, April 1, 2007; 119(4): 670 - 678.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. J. Greenlee, Z. Werb, and F. Kheradmand
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Physiol Rev, January 1, 2007; 87(1): 69 - 98.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
O. Altiok, R. Yasumatsu, G. Bingol-Karakoc, R. J. Riese, M. T. Stahlman, W. Dwyer, R. A. Pierce, D. Bromme, E. Weber, and S. Cataltepe
Imbalance between Cysteine Proteases and Inhibitors in a Baboon Model of Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 318 - 326.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
R. H. Hubner, S. Meffert, U. Mundt, H. Bottcher, S. Freitag, N. E. El Mokhtari, T. Pufe, S. Hirt, U. R. Folsch, and B. Bewig
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation
Eur. Respir. J., March 1, 2005; 25(3): 494 - 501.
[Abstract] [Full Text] [PDF]